2024 annual financial data
AnaptysBio 2024 Operating margin
Direct answer
Operating margin was -125.93%.
Operating income was -114,949,000 USD and net income was -145,231,000 USD.
Operating cash flow was -135,337,000 USD.
Get free AnaptysBio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 91,280,000 USD
- Operating income
- -114,949,000 USD
- Net income
- -145,231,000 USD
- Operating cash flow
- -135,337,000 USD